|
MFTH is our latest micro-cap Buzz Stock
Our latest micro-cap Buzz Stock, Medisafe 1 Technologies Corp. (OTCBB: MFTH) is a biotech company with a patented technology that has the potential to save lives.
Let's start off with the 3 S's we always look for in any potential winner:
Story: "Within just a few months, Medisafe 1 Technologies has been able to develop a commercially viable product for the multi-billion dollar healthcare industry," said Jacob Elhadad, CEO of MFTH, in a recent press release.
MFTH's product is a safety-locking device for syringes. The company recently conducted an official demonstration of its barcoded syringe locking device at Israel's National Ministry of Health, and received an official endorsement for the national implementation of the device from Israel's Pharmaceuticals Administration. Following the official endorsement, MFTH has been in discussions with a leading Israeli pharmaceuticals company to partner in streamlining the production process for the introduction of the device at Israeli Medical Centers, according to a press release. (Full press release: http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-97197790.html?x=0&.v=1)
Sector: According to MFTH's Web site, the direct annual cost of preventable, drug related mortality and morbidity is $177.4 billion! (http://www.medisafe1.com/product.html). Medication administration errors in hospitals cause an astonishing 400,000 preventable drug-related injuries and 7,000 deaths each year. MFTH's device has the potential to reduce instances of such injuries by physically preventing incorrect medications or improper dosages from being administered to a patient.
Substance: MFTH has the world's first U.S. patented technology to eliminate administration of incorrect medicinal substances by hypodermic needle (Patent No. 7,347,841 B2 granted on: March 25, 2008).
MFTH's patented safety locking-device for syringes is configured to work with a medical center's electronic Barcoding Point of Care (BPOC) data system. Using a barcode reader, the device confirms that the medication and dosage contained within a syringe are correctly intended for a medical patient. Upon electronic confirmation, the syringe locking-device opens, allowing for the administration of the syringe's contents.
Start your research here: http://www.medisafe1.com/home.html
On Monday, MFTH announced that it expects revenues in 2012 to exceed $10 million!
Discussions for licensing the technology are already underway in Israel, where the technology is expected to eventually be implemented across the State's nationwide medical system, the press release stated.
"Many reputable organizations and companies have expressed the value they recognize in our technologies," said, Jacob Elhadad, CEO of Medisafe 1 Technologies in a statement. "Through the further development of existing marketing channels, and the mass production of our licensed products, we expect reporting revenues in 2012 to exceed $10 million." (Full press release: http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-1473272581.html?x=0&.v=1)
The company has also taken steps to expand its reach and market applications, and has received positive feedback from its participation at two leading healthcare conferences.
Last week, MFTH announced that it has initiated discussions to implement its pre-matching safety locking device technology for blood transfusion vials with Israel's national Emergency Medical Services Provider, which oversees the nation's blood banks.
The company stated that it is in discussions with Israel's Magen David Adom, or Red Shield of David, which is the international equivalent of the Red Cross or Red Crescent.
MFTH's technology is already developed for syringes in hospitals, and the company estimates the application of the technology for infusion bags will be ready for demonstration within three months time. (Full press release: http://finance.yahoo.com/news/The-State-of-Israels-prnews-2023544273.html?x=0&.v=1)
The buzz around MFTH is getting louder!
Last November, the company announced that it received "significant interest" in its device at the HealthAchieve Conference in Toronto.
More than 35 companies responded favorably, including some of the nation's largest medical suppliers, expressing interest in learning more about the potential widespread implementation of MFTH's device. (Full press release:http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-4137644727.html?x=0&.v=2)
MFTH also recently demonstrated its device at the Medica 2010 Conference in Germany. According to a recent news release, a poll of companies that viewed MFTH's demonstration, including manufacturers and distributors of syringes and related technologies, revealed significant interest in the syringe, producing the locking device under license, or marketing the device.
"The initial results of the Medica conference are overwhelmingly positive," Elhadad said in a statement. "The interest displayed in our technology has the potential to open up new business development channels in North America, Europe and Australia." (Full press release: http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-4013342869.html?x=0&.v=3)
MFTH has publicly stated that it plans to commence licensing its technology to commercial entities during the first quarter of 2011.
"The locking device has garnered significant interest from noteworthy entities, who are interested in employing our technology in hospitals to reduce loss of life through avoidable human errors, and in turn reduce hospital operating expenses.
"We look forward to entering the commercial phase of the product lifecycle," Elhadad stated in another press release. (Full press release: http://finance.yahoo.com/news/Medisafe-1-Technologies-prnews-1159517299.html?x=0&.v=1)
Over the past several months, MFTH has released several, VERY positive news releases, all of which point to future growth.
MFTH has developed its safety-locking device for syringes into a "commercially viable" product, and has received positive feedback from "many reputable organizations and companies" that have "expressed the value they recognize in [the company's] technologies."
Could 2011 be a breakout year for MFTH?
Happy Trading!
Buzz Stocks
Disclaimer:
THIS IS A PAID ADVERTISEMENT FOR THE COMPANY OR COMPANIES MENTIONED IN THIS PUBLICATION. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS NEWSLETTER OR ON OUR WEBSITE.
The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Our Web site and our newsletter are services of Longview Communications Corp., a media and advertising firm that is from time-to-time compensated by the companies profiled on this web site or in our newsletter. When compensated in shares, readers should be aware that it is our policy to liquidate all shares immediately. All direct and third party compensation received has been disclosed on our newsletter and/or our website in accordance with section 17(b) of the Securities Act of 1933.
Compensation: We have received twenty thousand dollars from a third party, Carolin Adler, for media and advertising services for Medisafe 1 Technologies, Inc.
|
